These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19221969)

  • 1. [Somatic factors in cognitive impairment].
    Etgen T; Brönner M; Sander D; Bickel H; Sander K; Förstl H
    Fortschr Neurol Psychiatr; 2009 Feb; 77(2):72-82. PubMed ID: 19221969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The disease panorama and hypertenion].
    Forsberg SA; Ljungberg S
    Lakartidningen; 1971 Apr; 68(17):2031-5. PubMed ID: 5580100
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma C-reactive protein is related to cognitive deterioration and dementia in patients with mild cognitive impairment.
    Xu G; Zhou Z; Zhu W; Fan X; Liu X
    J Neurol Sci; 2009 Sep; 284(1-2):77-80. PubMed ID: 19419739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute confusional states in the framework of internal medicine disorders].
    Frossard E
    Schweiz Rundsch Med Prax; 1990 Jun; 79(24):782-3. PubMed ID: 2367772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
    McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
    Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of cardiovascular, endocrine and metabolic diseases on hearing].
    Brusis T
    Laryngorhinootologie; 1989 Oct; 68(10):557-60. PubMed ID: 2684199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concepts in vascular cognitive impairment and pharmacotherapeutic implications.
    Rojas-Fernandez CH; Moorhouse P
    Ann Pharmacother; 2009 Jul; 43(7):1310-23. PubMed ID: 19584390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Depression and frontal dysfunction: risks for the elderly?].
    Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
    Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive failure in terminal kidney disease].
    Saele K; Sønnesyn H; Svarstad E; Aarsland D
    Tidsskr Nor Laegeforen; 2009 Feb; 129(4):296-9. PubMed ID: 19219095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The many-colored picture of endocrine crisis in clinical practice--psychological symptoms in hormonal emergencies].
    Horn B
    Praxis (Bern 1994); 1995 Feb; 84(7):191-6. PubMed ID: 7871305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary manifestations of endocrine and metabolic disorders.
    Brüssel T; Matthay MA; Chernow B
    Clin Chest Med; 1989 Dec; 10(4):645-53. PubMed ID: 2689069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.
    Knopman DS; Mosley TH; Catellier DJ; Coker LH;
    Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between ApoE epsilon4 and cognitive impairment after stroke.
    Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
    Dement Geriatr Cogn Disord; 2009; 27(6):525-33. PubMed ID: 19494491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semantic inhibition impairment in mild cognitive impairment: a distinctive feature of upcoming cognitive decline?
    Bélanger S; Belleville S
    Neuropsychology; 2009 Sep; 23(5):592-606. PubMed ID: 19702413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cognitive impairment.
    Boccellari A; Leary M; Zeifert P
    Focus; 1996 Feb; 11(3):1-4. PubMed ID: 11363152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial navigation testing discriminates two types of amnestic mild cognitive impairment.
    Laczó J; Vlcek K; Vyhnálek M; Vajnerová O; Ort M; Holmerová I; Tolar M; Andel R; Bojar M; Hort J
    Behav Brain Res; 2009 Sep; 202(2):252-9. PubMed ID: 19463709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression impairs executive functioning in Parkinson disease patients with low educational level.
    Kummer A; Harsányi E; Dias FM; Cardoso F; Caramelli P; Teixeira AL
    Cogn Behav Neurol; 2009 Sep; 22(3):167-72. PubMed ID: 19741326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive decline and dementia related to cerebrovascular diseases: some evidence and concepts.
    Pantoni L; Poggesi A; Inzitari D
    Cerebrovasc Dis; 2009; 27 Suppl 1():191-6. PubMed ID: 19342851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.